Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.
Invex raises $26m for clinical trials
22/05/2020 - 11:16
Related Data & Insights
-
Invex TherapeuticsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 175th Invex Therapeutics $459k 176th Nanollose $412k 177th DigitalX $346k 179th Ultima United $286k 180th Queste Communications $244k 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned People
Related Articles
13 Mar 2024
Arrow to raise $10m
05 Mar 2024
Peppermint raises $1.1m amid loss
19 Feb 2024
Hazer taps investors for $9m
14 Feb 2024
Alcock’s back, billionaires branch out
30 Jan 2024
Nicola Forrest establishes new foundation
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX